GPC
37
2
SRE
66
3
CSX
57
6
RHI
57
3
LB
41
7
PSA
56
5
AFL
49
3
PVH
57
5
BSX
70
2
CMS
60
2
FTI
76
3
FLR
55
6
SO
57
2
COF
58
3
AN
54
4
KHC
11
2
IPG
53
4
APH
67
3
AVGO
22
2
TXT
52
4
GPC
37
2
SRE
66
3
CSX
57
6
RHI
57
3
LB
41
7
PSA
56
5
AFL
49
3
PVH
57
5
BSX
70
2
CMS
60
2
FTI
76
3
FLR
55
6
SO
57
2
COF
58
3
AN
54
4
KHC
11
2
IPG
53
4
APH
67
3
AVGO
22
2
TXT
52
4
Financhill
Back

Entrada Therapeutics Vs. Regenxbio Industry Stock Comparison

Buy
58

TRDA
Entrada Therapeutics

Last Price:
18.85
Seasonality Move:
-29.61%
Sell
18

RGNX
Regenxbio

Last Price:
9.60
Seasonality Move:
-5.7%
Buy
58
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $18.05. The Score for TRDA is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
18
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $9.18. The Score for RGNX is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $18.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing slight buying pressure.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $9.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing selling pressure, which indicates risk of future bearish movement.

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.32 Buy
Relative Strength Index (14 RSI): 50.91 Buy
Chaikin Money Flow: 10625 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.04 - 19.04) Buy
Bollinger Bands (100): (15.03 - 17.89) Buy

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 43.02 Sell
Chaikin Money Flow: -473643 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.97 - 10.71) Sell
Bollinger Bands (100): (9.86 - 12.8) Sell

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.48 Sell
20-day SMA: 18.27 Sell
50-day SMA: 16.93 Buy
200-day SMA: 15.19 Buy
8-day EMA: 18.24 Sell
20-day EMA: 18.15 Sell
50-day EMA: 17.37 Buy
200-day EMA: 15.84 Buy

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.06 Sell
20-day SMA: 9.77 Sell
50-day SMA: 10.34 Sell
200-day SMA: 14.27 Sell
8-day EMA: 9.84 Sell
20-day EMA: 9.96 Sell
50-day EMA: 10.39 Sell
200-day EMA: 13.22 Sell

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and a decrease next year of $4.11 per share.

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $3.97 per share.

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):